A. , N. R. Richelson, E. Gilbert, J. A. Mccormick, D. J. Kanba et al., Structure-antinociceptive activity of neurotensin and some novel analogues in the periaqueductal gray region of the brainstem, Brain Res, vol.557, pp.227-235, 1991.

A. , M. Gully, D. Heaulme, M. Bérod, A. Pélaprat et al., Neurotensin receptor interaction with dopaminergic systems in the guinea-pig brain shown by neurotensin receptor antagonists, Eur. J. Pharmacol, vol.255, pp.167-174, 1994.

B. , C. D. Coury, A. Fibiger, H. C. And, and A. G. Phillips, Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: cross-validation using in vivo voltametry and microdialysis, Neuroscience, vol.34, pp.699-705, 1990.

B. , R. Gully, D. Jeanjean, F. And-molimard, and J. C. , New 3-amino-pyrazole for treatment of pathological states caused by dopaminergic system dysfunction. Eur, 1992.

B. , A. Heaulme, M. Leyris, R. Pélaprat, D. Gully et al., SR 48692 inhibits neurotensin-induced [ 3 H]dopamine release in rat striatal slices and mesencephalic cultures, Eur. J. Pharmacol, vol.253, pp.289-291, 1994.

B. , A. Pélaprat, D. Dana, C. Vial, M. Lhiaubet et al., Mesencephalic dopaminergic neurons in primary cultures express functional neurotensin receptors, J. Neurosci, vol.12, pp.1409-1415, 1992.

C. , R. E. And, and S. E. Leeman, The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami, J. Biol. Chem, vol.248, pp.6854-6861, 1973.

C. , R. S. Lotti, V. J. Chen, T. B. And, and K. A. Kunkel, Characterization of the binding of

C. , Y. C. And-prusoff, and W. H. , Relationship between the inhibition constant (K i ) and the concentration of inhibitor which causes 50 percent inhibition (IC 50 ) of an enzymatic reaction

D. , I. Costentin, J. Terranova, J. P. Barnouin, M. C. Soubrié et al., The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes, Br. J. Pharmacol, vol.112, pp.352-354, 1994.

E. , P. C. Goedert, M. Horsfield, P. M. Rioux, F. And et al., The regional distribution and chromatographic characterization of neurotensin-like immunoreactivity in the rat central nervous system, J. Neurochem, vol.38, pp.992-999, 1982.

G. , U. Johansen, T. E. Snider, R. M. Lowe-iii, J. A. Nakanishi et al., Different binding epitopes on the NK1 receptor for substance P and non-peptide antagonist, Nature, vol.362, pp.345-348, 1993.

G. , D. Canton, M. Boigegrain, R. Jeanjean, F. Molimard et al., Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of neurotensin receptor

H. , D. Tassin, J. P. Studler, J. M. Dana, C. Kitabgi et al., Dopaminergic control of 125 I-labeled neurotensin binding site density in corticolimbic structures of the rat brain, Proc. Natl. Acad. Sci. USA, pp.6203-6207, 1986.

J. , C. J. Gerard, N. P. Schwartz, T. W. And-gether, and U. , The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors, Mol. Pharmacol, vol.45, pp.294-299, 1994.

K. , E. Bullock, B. Mcniel, S. And-dobner, and P. , The rat gene encoding neurotensin and neuromedin N: Structure, tissue-specific expression, and evolution of axon sequences, J Biol Chem, vol.263, pp.4963-4968, 1988.

K. , P. Checler, F. Mazella, J. And, and J. P. Vincent, Pharmacology and biochemistry of neurotensin receptors, Rev. Basic Clin. Pharmacol, vol.5, pp.397-486, 1985.

K. , P. Labbé-jullié, C. Mas, M. V. Botto, J. M. Chabry et al., [ 3 H]SR 48692, a new nonpeptide neurotensin antagonist radioligand, reveals distinct agonist and antagonist binding domains on the rat neurotensin receptor, Society for Neuroscience Abstracts, vol.20, p.27, 1994.

K. , P. And-nemeroff, and C. B. , The Neurobiology of Neurotensin, Ann. N.Y. Acad. Sci, vol.668, pp.1-371, 1992.

K. , P. Rostène, W. Dussaillant, M. Schotte, A. Laduron et al., Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution, Eur. J. Pharmacol, vol.140, pp.285-293, 1987.

L. , C. Dubuc, I. Brouard, A. Doulut, S. Bourdel et al., In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes, J. Pharmacol. Exp. Ther, vol.268, pp.328-336, 1994.

M. , J. Triepel, K. J. And, and J. Metz, Neurotensin in the human brain, Neuroscience, vol.22, pp.499-524, 1987.

M. , T. Baldwin, and G. S. , The seventh transmembrane domain of gastrin/CCK receptors contributes to non-peptide antagonist binding, Biochem. Biophys. Res. Commun, vol.201, pp.1382-1389, 1994.

M. , E. Rostène, W. Vial, M. Leonard, K. Mazella et al., Distribution of neurotensin binding sites in rat brain: A light microscopic radioautographic study using monoiodo [ 125 I]Tyr 3 -neurotensin, Neuroscience, vol.22, pp.525-536, 1987.

M. , P. J. And-rodbard, and D. , LIGAND: A versatile computerized approach for characterization of ligand-binding systems, Anal. Biochem, vol.107, pp.220-239, 1980.

N. , A. Bérod, A. Gully, D. Rowe, W. Quirion et al., Blockade of neurotensin binding in the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonists, Neuroendocrinology, vol.59, pp.572-578, 1994.

N. , A. Rostène, W. And, and A. Bérod, Neurotensin receptor expression in the rat forebrain and midbrain: A combined analysis by in situ hybridization and receptor autoradiography, J. Comp. Neurol, vol.341, pp.407-419, 1994.

P. , J. M. And, and M. J. Kuhar, Neurotensin receptors are located on dopamine-containing neurons in the rat midbrain, Nature, vol.294, pp.587-589, 1981.

P. , G. And, and C. Watson, The Rat Brain in Stereotaxic Coordinates, 1986.

P. , D. J. Totaro, J. A. Harris, E. And-robinson, and F. M. , Heterogeinity of 3 H neurotensin binding: studies with dynorphin, L-156,903 and levocabastine, Brain Res, vol.457, pp.212-218, 1988.

Q. , R. Chiueh, C. Everist, H. And, and A. Pert, Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals, Brain Res, vol.327, pp.385-389, 1985.

R. , C. And-bacchelli, and B. , The brain of the guinea pig in stereotaxic coordinates, Arch. Sci. biol, vol.61, pp.1-37, 1977.

R. , W. Brouard, A. Dana, C. Masuo, Y. Agid et al., Interaction between neurotensin and dopamine in the brain: Morphofunctional and clinical evidence, Ann. N.Y. Acad. Sci, vol.668, pp.217-231, 1992.

S. , J. L. Kitabgi, P. Rostène, W. Javoy-agid, F. And et al., Characterization and visualization of neurotensin binding to receptor sites in human brain, Biochem. Biophys. Res. Commun, vol.120, pp.206-213, 1984.

S. , J. L. Mazella, J. Amar, S. Kitabgi, P. And et al., Preparation of neurotensin selectively iodinated on the tyrosine 3 residue. Biological activity and binding properties on mammalian neurotensin receptors, Biochem. Biophys. Res. Commun, vol.120, pp.812-819, 1984.

S. , A. Javoy-agid, F. Kitabgi, P. Dussaillant, M. Vial et al., Characterization and autoradiographic distribution of neurotensin binding sites in the human brain, Brain Res, vol.348, pp.375-380, 1985.

S. , A. Leysen, J. E. And-laduron, and P. M. , Evidence for a displaceable non-specific [ 3 H] neurotensin binding site in rat brain, Naunyn-Schmiedeberg's Arch. Pharmacol, vol.333, pp.400-405, 1986.

S. , A. Rostène, W. And, and P. M. Laduron, Different subcellular localization of neurotensin receptor and neurotensin acceptor sites in the rat brain dopaminergic system, J. Neurochem, vol.50, pp.1026-1033, 1988.

S. , V. Massotte, L. And, and A. Dresse, Electrophysiological effects of neurotensin on dopaminergic neurones of the ventral tegmental area of the rat in vitro, Neuropharmacology, vol.28, pp.949-954, 1989.

S. , S. Escrieut, C. Dufresne, M. Martinez, J. Bouisson et al., Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor, Mol. Pharmacol, vol.45, pp.599-607, 1994.

S. , E. And, and A. Beaudet, Correspondence between high affinity 125 I-neurotensin binding sites and dopaminergic neurons in the rat substantia nigra and ventral tegmental area: A combined radioautographic and immunohistochemical light microscopic study, J. Comp. Neurol, vol.279, pp.128-137, 1989.

T. , V. D. Fortune, K. P. Pollo, D. A. Shah, G. N. Wank et al., Direct demonstration of three different states of the pancreatic cholecystokinin receptor, Proc. Natl. Acad

T. , K. Masu, M. And-nakanishi, and S. , Structure and functional expression of the cloned rat neurotensin receptor, Neuron, vol.4, pp.847-854, 1990.

V. , N. Laurent, P. Lefort, S. Chalon, P. Dumont et al., Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor, FEBS Lett, vol.317, pp.139-142, 1993.

W. , M. Robberecht, P. Chatelain, P. And-christophe, and J. , Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high-and low-affinity binding sites, Mol. Pharmacol, vol.21, pp.581-588, 1982.